ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2026
Sex-Based Differences in Mitral Annular Disjunction Severity and Arrhythmic Risk in Mitral Valve Prolapse.
Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Arrhythmic Mitral Valve Prolapse as a Regional Stretch-Induced Cardiomyopathy with Fibro-Inflammatory Signature: A Conceptual Review.Journal of cardiovascular development and disease · 2026Review
- Leveraging Self-Reporting in an Existing e-Cohort to Identify Clinically Relevant Mitral Valve Prolapse: Pilot Questionnaire Study.JMIR formative research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundArrhythmic mitral valve prolapse (AMVP), a condition with known female predominance, has been linked to mitral annular disjunction (MAD), yet the relationship between MAD, sex, body size, and arrhythmic events remains unclear.
objectivesTo determine whether MAD exhibits sex-based differential effects on arrhythmic risk and explore the implications of indexing MAD measurements.
methodsWe examined 682 consecutive MVPs at the University of California San Francisco (2013-23) with detailed clinical, rhythmic, and echocardiographic data. Mitral annular disjunction was indexed to body surface area, resulting in the identification of 3 distinct groups: no MAD and indexed MAD (iMAD) below and iMAD above the median. Arrhythmic mitral valve prolapse was defined as MVP with frequent and/or complex ventricular ectopy, including severe arrhythmic events such as sustained ventricular tachycardia, ventricular fibrillation/sudden cardiac arrest, or death.
resultsAmong 682 MVP patients (48% women, mean age 58 ± 17 years), 35% had AMVP and 41% had MAD, with a median iMAD of 4 mm. Compared to women, men had greater absolute MAD length (9.0 ± 3.2 mm vs 7.3 ± 2.6, P < .001). Sex-based differences in MAD length were no longer appreciated after indexing for body surface area (P = .33). In multivariable analyses, iMAD >4 mm was significantly associated with arrhythmic events in men but not in women (P = .02 vs P = .63). Bileaflet MVP had a direct effect on severe arrhythmic events in women (P = .04 for MVP, P = .39 in mediation analysis), but in men this association was mediated by iMAD length (P = .03).
conclusionIn a large MVP cohort, men exhibit greater MAD length and a stronger association between iMAD length and arrhythmic events. In contrast, iMAD length in women may be less important for arrhythmic risk stratification compared to other imaging parameters such as bileaflet involvement. Further studies are needed to confirm alternative mechanisms beyond localized MAD-related myocardial traction in women with MVP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.